Home › Depression › NCT06917339
Retrospective Analyses of TrakStar Database
RecruitingObservational study
Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes
Who can join
Ages 5 to 120 · All sexes
Full eligibility criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date of November 01, 2008 or later. Exclusion Criteria: • Incomplete information on treatment parameters
About the study
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
What is being tested
- NeuroStar Advanced TMS Therapy System (device)
Sponsor: Neuronetics · Participants: 156,000 · Started: Feb 25, 2025
Contact the study team
- Neha Goyal · Phone: 763-528-1599
- Eleanor Cole, PhD · Phone: 415-724-7960
Official record on ClinicalTrials.gov — NCT06917339
Locations in the U.S.
| Pennsylvania | Neuronetics, Malvern |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.